Dong-A Socio Holdings Co. Ltd. completed the acquisition of additional 2.7% stake in Dong-A ST Co.,Ltd from Jung-Seok Kang, ST Pharm Co. Ltd., Sangju Academy and others.
October 27, 2014 at 04:00 am
Share
Dong-A Socio Holdings Co. Ltd. (KOSE:A000640) made an offer to acquire additional 2.7% stake in Dong-A ST Co.,Ltd (KOSE:A170900) from Jung-Seok Kang, ST Pharm Co. Ltd., Sangju Academy and others for KRW 19.9 billion on September 2, 2014. Under the terms of the deal, 0.2 million shares are to be acquired at an offer per share of KRW 99400. The transaction will be funded by issue 0.16 million new shares. The tender offer period is October 8, 2014 to October 27, 2014 and payment date is October 29, 2014.
As of October 6, 2014, Dong-A Socio Holdings Co. Ltd. decided to issue 0.14 million shares at the price of KRW 0.14 million per share for net proceeds of KRW 19.88 billion and fund the transaction. The exchange ratio of the stocks of Dong-A ST Co. to Dong-A Socio Holdings is 1: 0.7098529. Woori Investment & Securities Co. Ltd. acted as broker in the transaction.
Dong-A Socio Holdings Co. Ltd. (KOSE:A000640) completed the acquisition of additional 2.7% stake in Dong-A ST Co.,Ltd (KOSE:A170900) from Jung-Seok Kang, ST Pharm Co. Ltd., Sangju Academy and others on October 27, 2014.
STPharm Co.,Ltd. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The Company's products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The Company distributes its products within domestic market and to overseas markets.
Dong-A Socio Holdings Co. Ltd. completed the acquisition of additional 2.7% stake in Dong-A ST Co.,Ltd from Jung-Seok Kang, ST Pharm Co. Ltd., Sangju Academy and others.
ST PHARM CO.,LTD. 
